Introduction {#s1-2}
============

In Western Europe *Cryptococcus gattii* infections have increased during the last two decades \[[@R1]\]. *C. gattii* can cause severe systemic disease in immunocompromised and immunocompetent hosts \[[@R2]\]. *Cryptococcal* yeasts usually enter the host via the respiratory tract \[[@R2]\]. Pulmonary symptoms as well as radiographic features and clinical parameters are mostly unspecific and often lead to misdiagnosis \[[@R5]\]. Both *Cryptococcus neoformans* and *C. gattii* species complexes show a high affinity for the central nervous system \[[@R6]\]. The median incubation time is six to seven months \[[@R7]\]. By using molecular techniques, such as restriction fragment length polymorphism (RFLP), PCR fingerprinting, multi-locus sequence typing (MLST) and amplified fragment length polymorphism (AFLP) fingerprinting it was observed that *C. gattii* species complex can be differentiated into five distinct genotypes \[[@R1]\]. Due to epidemiological, genetic and ecological differences the taxonomy of the *C. neoformans*/*C. gattii* species complexes have been recently thoroughly revised and the five *C. gattii* species complex genotypes were all raised to species as *C. gattii sensu stricto* (genotype AFLP4/VGI), *Cryptococcus bacillisporus* (genotype AFLP5/VGIII), *Cryptococcus deuterogattii* (genotype AFLP6/VGII), *Cryptococcus tetragattii* (genotype AFLP7/VGIV) and *Cryptococcus decagattii* (genotype AFLP10) \[[@R9]\]. The globally occurring species *Cryptococcus gattii s.s.* and *C. deuterogattii* are often involved in disease in apparently immunocompetent subjects, while the other three species are geographically restricted and have a predilection for immunocompromised hosts, mostly HIV-infected individuals \[[@R9]\]. An ongoing outbreak in British Columbia (Canada) that was first recognized in 1999 and started on Vancouver Island, was found to be caused by the rare genotype AFLP6/VGII (=*C. deuterogattii*). The outbreak expanded to the Pacific Northwest of the USA, although different subgenotypes were involved \[[@R10]\] and has affected the health of hundreds of humans, and many more animals living in that area \[[@R12]\]. In Germany, less than 25 hospitalizations for cryptococcosis are listed per year with 3 % documented *C. gattii s.l.* infections. As molecular analysis identified that only half of the infections were acquired abroad \[[@R1]\], identification of environmental niches occupied by *C. gattii s.l.* in Germany is an important challenge to assess the associated risk of infection \[[@R14]\]. Here we report a fatal case of cryptococcosis due to *C. deuterogattii* infection that was likely to have been acquired on Vancouver Island two years before the onset of disease.

Case report {#s1-3}
===========

A 49-year-old woman was hospitalized in the University Hospital Halle/Saale, Germany, with an acute presentation of headache, discrete ataxia and impaired vision. No episodes of pyrexia were reported. Serum inflammatory markers were inconspicuous with only a slight leukocytosis (14.53 Gpt l^−1^). Cranial magnetic resonance imaging (MRI) revealed a contrast-enhancing lesion with surrounding edema in the left cerebellum hemisphere next to the cerebellar pedunculus ([Fig. 1](#F1){ref-type="fig"}a, b). In addition, computed tomography (CT) showed a small hyperintense subpleural nodule in the right lower lung lobe ([Fig. 1e](#F1){ref-type="fig"}). To rule out malignancy the cerebellar lesion was surgically biopsied via a suboccipital craniotomy. A frozen section contained paucicellular glial tissue without signs of malignancy, purulence or specific infection ([Fig. 1](#F1){ref-type="fig"}c, d). Postoperatively, the patient developed cerebral edema with displacement and compression of the fourth ventricle and the brainstem. Severe increase of intracranial pressure required suboccipital craniotomy and application of cerebrospinal fluid (CSF) drainage. A microbiological examination of the liquor was not carried out as there was no suspicion of an infection. Despite extensive supportive care the clinical condition did not improve and ten days after hospitalization the patient died. An autopsy demonstrated a purulent pneumonia with punctum maximum in the right inferior lung lobe. In addition, further processing of the cerebral biopsy was undertaken, including PAS and Grocott staining. These revealed the image of cerebral cryptococcosis with presentation of typical capsule, highlighted fungi next to a surrounding histiocyte-rich inflammation with abundance of foam cells and a rare lymphocytic infiltrate ([Fig. 2](#F2){ref-type="fig"}a, b). The same pathogens were also seen in the inflamed pulmonary tissue ([Fig. 2](#F2){ref-type="fig"}c, d). Cryptococcal DNA was amplified by a broad-range PCR assay targeting the ITS2 region of the ribosomal DNA. The amplicon was identified as *C. gattii* by LCD-Chip hybridization (LCD array fungi 2.1; Chipron). Natural reservoirs for *C. gattii* are found in Australia, Asia, Africa and some regions of America, including Vancouver Island which has been determined to be an endemic area \[[@R1]\]. In contrast, infection in Europe is rare, although *C. gattii* has been previously isolated in Greece, southern Italy and Spain \[[@R15]\]. When confronted with the autopsy results the relatives of the deceased mentioned that she spent her holidays on Vancouver Island two years prior her death. Tissue samples were transmitted to the Robert-Koch Institute (Berlin, Germany) where molecular pathogen analysis was confirmed by amplification of the IGS region of the ribosomal DNA with amplicon detection by LCD-Chip hybridization using a commercial system (Chipron) and ITS2 PCR with amplicon sequencing \[[@R16]\]. Subsequently in Nijmegen, the Netherlands, a standard multi-locus sequence typing analysis was performed \[[@R1]\], which did not yield any PCR product due to the fragmented formalin-fixed paraffin-embedded (FFPE)-DNA. Therefore a FFPE-MLST scheme was developed to cover the most variable parts of each of the seven standard MLST-loci ([Table 1](#T1){ref-type="table"}). PCRs and sequencing were performed as described previously \[[@R1]\]. Using the FFPE-MLST it was determined that the involved cryptococcal strain was *C. deuterogattii*, formerly known as *C. gattii* genotype AFLP6/VGII. By using phylogenetic analysis, it was determined that this strain clustered within the clade of Vancouver-Island-outbreak-related *C. deuterogattii* strains ([Fig. 3](#F3){ref-type="fig"}), which supports the earlier suggestion that the patient acquired the cryptococcal infection during her holiday to Vancouver Island.

![Preoperative and intraoperative diagnostic investigations. Cranial magnetic resonance imaging (a and b) showing a circumscribed mass in the left cerebellum hemisphere (arrows). Further investigations included a chest computed tomography (e) with presentation of a subpleural nodule in the right lower lobe (arrow). An intraoperative frozen section (c and d) revealed paucicellular glial tissue with several infiltrating immune cells.](jmmcr-5-5168-g001){#F1}

![Postmortem diagnostic investigations. Cerebellar tissue (a and b) showing single immune cells next to some poorly demarcating spherules in HE-staining. Assessment of lung tissue (c and d) revealed a purulent pneumonia with presentation of several foci with the same round and oval structures (Arrows). Further staining of the cerebellar tissue as well as of the lung tissue including PAS reaction and Grocott staining supported the assumption that this was due to *Cryptococcus*.](jmmcr-5-5168-g002){#F2}

###### Newly designed *Cryptococcus gattii sensu lato* FFPE-MLST primers

  Locus           Primer name               Primer sequence\*
  --------------- ------------------------- ------------------------
  CAP59           FFPE-CAP59Fwd             AGGCGAGGCAGCACAAGTA
  FFPE-CAP59Rvd   TTTGTCTGGTCGTTGGAACC      
  GPD1            FFPE-GPD1Fwd              AGGTCGTATCGGTCGAATTG
  FFPE-GPD1Rvd    CCATGTAGTCCAAGTCAATGAAA   
  IGS1            FFPE-IGS1Fwd              TTGGCTAAGATGCGTTATGC
  FFPE-IGS1Rvd    TTGCTTGACCGAGCTTGACT      
  LAC1            FFPE-LAC1Fwd              CATGGTATGCGGCAGAAG
  FFPE-LAC1Rvd    AAGCCTATGGTACSTCATCAGC    
  PLB1            FFPE-PLB1Fwd              CGTGGATTAGAAATGCCACTGT
  FFPE-PLB1Rvd    TTCGGTGCTTTCATTCATCA      
  SOD1            FFPE-SOD1Fwd              ACTCTGAGAGGCACGTTGGT
  FFPE-SOD1Rvd    TGATGGAGTAAGGGCCAAAG      
  URA5            FFPE-URA5Fwd              AGGCCGGTGAGCCATATC
  FFPE-URA5Rvd    CGTCCTTCTTCTCCTTCCTG      

\*All primers have a Tm of 60 °C, PCRs were performed as described previously \[[@R1]\].

![Phylogenetic analysis Using phylogenetic analysis, it was observed that this strain clustered within the clade of Vancouver-Island-outbreak-related *C. deuterogattii* strains.](jmmcr-5-5168-g003){#F3}

Discussion {#s1-4}
==========

*Cryptococcus* is a common yeast fungus with a natural reservoir on decaying wood and bird droppings \[[@R12]\]. Until recently, the genus *Cryptococcus* included over 100 species, but after a thorough taxonomic revision only ten remained \[[@R9]\]. Members of the *C. gattii* species complex, which is common in Sub-Saharan Africa, Asia, Australia, Europe, South and North America, can infect persons without immunodeficiency \[[@R2]\]. As a diagnostic challenge, the patients do not present typical clinical or laboratory findings. Furthermore, it has been reported that the infection first involves the pulmonary tract and spreads secondarily to organs, especially the central nervous system \[[@R18]\]. Frequently, the patients present with a respiratory syndrome with cough, dyspnea and chest pain while neurological symptoms, like headache and neck stiffness, as well as night sweats, weight loss and anorexia may occur afterwards \[[@R2]\]. Additionally, it has been reported that the clinical symptoms and the progression of the disease differ between species within the *C. gattii* species complex \[[@R12]\], even *in vitro* antifungal susceptibility varies \[[@R21]\]. Concerning the case presented here, a woman with cough over a period longer than one year suddenly developed acute headache, discrete ataxia and impaired vision. Initially, the blurred mass in the cerebellum together with the subpleural nodule in the right lower lung lobe was misinterpreted as malignancy, a finding that is described in several other reports \[[@R5]\]. The hypothesis of malignancy was further supported by clinical and laboratory findings, as the patient had no fever and only mild leukocytosis. Finally, the diagnosis of cryptococcosis was only made post mortem after histopathological and molecular-pathological evaluation. A main reason for the delayed diagnosis is the lack of experience due to the low incidence in an unexpected patient group. It should also be noted that the time between infection and the first clinical symptoms was uncommonly long, compared with a reported median incubation time of between six and seven months \[[@R7]\]. According to data from the Robert Koch Institute in Berlin, Germany, only three percent of 155 cases of cryptococcosis were related to *C gattii s.l.* between 2004 and 2013 \[[@R13]\] and surveillance is challenging because fungal infections are not notifiable diseases. The available data indicate that there was no significant increase of cryptococcosis during that period \[[@R14]\]. However, in terms of health policy it is meaningful that *C. gattii s.l.* infections might also occur in Northern Europe, probably as a consequence of climate change \[[@R14]\]. Therefore, nowadays this fungal pathogen is not only restricted to tropical and subtropical regions \[[@R14]\] and endemic areas for *C. gattii s.l.* within Europe have been described \[[@R1]\]. In 2012 the fungus was isolated from a tree in the Netherlands \[[@R27]\] and earlier *C. gattii s.l.* was detected in Italy, Greece, Portugal, and Spain \[[@R1]\]. Furthermore, in Germany few cases of cryptococcosis due to *C. gattii s.s.* without a travel history to endemic regions have been documented \[[@R14]\]. Nonetheless at least half of the infections in Germany were acquired abroad \[[@R1]\]. In summary, it is important that clinicians are aware of this challenging invasive mycosis that often infects immunocompetent subjects. Unspecific symptoms with cough in conjunction with acute cerebral symptoms are indicators for the diagnosis and it has to be pointed out that an early diagnosis allows cure of the majority of patients, albeit that despite effective treatment central nervous complications may persist \[[@R6]\].

Conclusion {#s2-4-1}
----------

In Western Europe, increased international travel leads to a rising number of infections with rare pathogens \[[@R29]\]. Additionally climate change creates new ecological niches in the environment. *C. gattii*, which has been formerly known to be a pathogen in tropical and subtropical regions \[[@R2]\], has been recognized in temperate regions in Europe and North America \[[@R1]\]. In consequence of the lack of experience due to the low incidence in a particularly unexpected group of patients, determination of the diagnosis is often delayed and findings are misinterpreted \[[@R13]\]. Early diagnosis is critical for a successful treatment of this otherwise lethal infection mostly due to central nervous complications \[[@R6]\].

Abbreviations: FFPE, Formalin-fixed paraffin-embedded tissue; LCD-Chip, Low Cost Density Chip; MLST, Multi-locus sequence typing; PAS, Periodic acid--Schiff stain; s.l., sensu lato; s.s, sensu stricto.
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